Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus HMG versus HMG alone for ovulation induction in infertile women with polycystic ovary syndrome undergoing ICSI
ACTRN12614000025639Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of letrozole, urofollitropin and human chorionic gonadotropin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Alexandria University. Primary endpoints: Number of oocytes retrieved and Number of mature oocytes. Started Jan 2014; status: completed.
02
Drugs
letrozoleurofollitropinhuman chorionic gonadotropin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ACTRN12614000025639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000025639.